GSC
ALDX icon

Ground Swell Capital’s Aldeyra Therapeutics ALDX Stock Holding History

Ground Swell Capital’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-188
Closed -$1K – 2392
2014
Q2 		$1K Buy
+188
New +$1.26K ﹤0.01% 1679

Other funds holding ALDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Ground Swell Capital's ALDX Position: Q3 2014 in Review

Ground Swell Capital sold out of Aldeyra Therapeutics (ALDX) in Q3 2014, closing a stake of 188 shares — an estimated $1K sold.

Ground Swell Capital first reported a position in ALDX in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 7 funds tracked by Wall St. Rank hold ALDX as of Q3 2014.

  • Ground Swell Capital reported no remaining Aldeyra Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 188 Aldeyra Therapeutics shares in Q3 2014, an estimated $1K.
  • Ground Swell Capital first reported a position in Aldeyra Therapeutics in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Aldeyra Therapeutics position peaked at $1K in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.